Yuzhen Zhang
State Key Laboratory Of Virology And Biosafety
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice.
Journal: Frontiers in cellular and infection microbiology
Published: August 22, 2025
A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression.
A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression.
Journal: Virologica Sinica
Published: June 09, 2025
Whole-cell response of coronavirus-infected BMDCs through proteomic and transcriptomic analyses.
Journal: Frontiers in immunology
Published: November 11, 2024
Epitranscriptomic m5C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection.
Journal: Science advances
Published: August 07, 2024
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Journal: Emerging microbes & infections
Published: May 16, 2024
A long-term cohort study: the immune evasion and decreasing neutralization dominated the SARS-CoV-2 breakthrough infection.
Journal: Frontiers in cellular and infection microbiology
Published: February 04, 2024
Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.
Journal: Signal transduction and targeted therapy
Published: March 22, 2023
Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice.
Journal: Emerging microbes & infections
Published: August 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026